O. I. Lemeshevskaya

O. I. Lemeshevskaya

Auto-generated profile, based on publicly available information

O. I. Lemeshevskaya

Saint Petersburg State University, Institute of Medicine

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2024 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
OLO.I. Lemeshevskaia
O.I. Lemeshevskaia
LSLidiia Alexandrovna Soprun
Lidiia Alexandrovna Soprun
EKEvelina Kamaeva
Evelina Kamaeva
MLM.V. Lukashenko
M.V. Lukashenko
NGNatali Gavrilova
Natali Gavrilova
Objective. To evaluate the autonomic dysfunction of cardiovascular system (CVS) in patients with post-COVID syndrome with the help of active orthotest and heart rate variability methods. Material and methods. 70 patients with PCOS were examined, who were divided into 2 groups. Group 1 patients received standard therapy and Cytoflavin for 35 days, Group 2 patients received only standard therapy. Patients were examined by a neurologist in dynamics, the severity of asthenic syndrome was assessed on the MFI-20 scale, HRV and orthostatic test parameters. Results. When assessing HRV, an increase in the activity of humoral and nervous levels of CVS regulation was observed, which decreased against the background of cytoflavin therapy. Prior to the start of treatment, the activity of the parasympathetic department prevailed in patients, despite a decrease in its reactivity. All patients had a change in parasympathetic regulation, and therefore they were divided into subgroups with excessive and insufficient parasympathetic activity. Against the background of therapy, the elimination of differences between the groups with normalization of the main HRV indicators was observed. The severity of asthenia decreased after the course of treatment (values on the MFI-20 scale, p=0.0498). Conclusion. In patients with PKS, signs of dysautonomia were revealed, the probable cause of which may be autonomic neuropathy with a predominant lesion of the parasympathetic link. The use of Cytoflavin can have a significant positive effect in the complex treatment of such patients.

25 July 2023 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
OLO.I. Lemeshevskaia
O.I. Lemeshevskaia
EKEvelina Kamaeva
Evelina Kamaeva
MLM.V. Lukashenko
M.V. Lukashenko
NGNatali Gavrilova
Natali Gavrilova
LSLidiia Alexandrovna Soprun
Lidiia Alexandrovna Soprun
A clinical observation of the use of Cytoflavin according to a two-stage scheme (10.0 ml intravenously drip per 200 ml of 0.9% sodium chloride solution for 10 days, followed by a transition to a tablet form of 2 tablets 2 times/day for 25 days) in a patient with postcovid syndrome with pronounced vegetative and neurocognitive disorders. The effectiveness of therapy was confirmed by an improvement in heart rate variability and a decrease in the severity of depression, anxiety (on the HADS scale) and the level of autonomic dysfunction (on the COMPASS-31 scale). The significant changes in levels of fatigue (on a scale MFI) is not marked. The obtained results can serve as a basis for further research.

3 July 2026 in Voprosy onkologii
Verified
Journal Article
Open access
ЭТЭльдар Эскендерович Топузов
Эльдар Эскендерович Топузов
ВСВиталий Александрович Скворцов
Виталий Александрович Скворцов
РОРашида Вахидовна Орлова
Рашида Вахидовна Орлова
ОЛОльга Игоревна Лемешевская
Ольга Игоревна Лемешевская
SISergei Vitalyevich Ivanov
Sergei Vitalyevich Ivanov
Введение. Совместно с увеличением количества аллопластических реконструктивных вмешательств на молочной железе растет и распространенность осложнений. При этом, несмотря на многочисленные имеющиеся зарубежные исследования, единое мнение относительно факторов риска развития инфекционных осложнений на данный момент отсутствует. Цель. Выявить предикторы развития инфекционных осложнений в группах одномоментной и отсроченной реконструкции молочной железы. Материалы и методы. В ретроспективное когортное исследование было включено 267 пациенток, обратившихся в СПб ГБУЗ «ГКОД» с 2014 по 2021 г. Им была проведена одномоментная или отсроченная реконструкция молочной железы с применением экспандера и/или имплантата. Регистрируемым событием являлось развитие инфекционного осложнения, определяемое в соответствии с критериями CDC/NHSN для хирургических инфекций. Изучались демографические показатели пациенток, анамнестические данные, характеристики заболевания и оперативного вмешательства, полученное лечение. Результаты. Инфекционные осложнения развились у 19 из 141 пациенток после одномоментной реконструкции (13,5 %) и у 13 из 128 пациенток после отсроченной реконструкции (10,2 %). По результатам однофакторного анализа были отобраны факторы для включения в модели бинарной логистической регрессии отдельно для каждого типа реконструкции. Результат pinch-теста, равный 0–5 мм, был статистически значимо связан с развитием инфекционных осложнений в обеих группах (aOR = 4,968 [95 % ДИ 1,702; 14,498], р = 0,003 в модели для одномоментной реконструкции и aOR = 4,717 [95 % ДИ 1,196; 18,597], р = 0,027 для отсроченной). Курение (aOR = 8,887 [95 % ДИ 1,433; 55,119], р = 0,019) и ИМТ (aOR = 1,161 [95 % ДИ 1,018; 1,323], р = 0,026) выступили в роли факторов риска в группе одномоментной реконструкции, а в группе отсроченной реконструкции — адъювантная лучевая терапия до реконструктивной операции (aOR = 18,090 [95 % ДИ 1,594; 52,322], р = 0,019). Выводы. В роли предикторов развития инфекционных осложнений в обеих группах выступил результат pinch-теста, равный 0–5 мм. Факторами риска также являлись индекс массы тела и курение в группе одномоментной реконструкции, а также проведение лучевой терапии в группе отсроченной реконструкции.

29 June 2026 in Nephrology and Dialysis
Verified
Journal Article
Closed access
OLO. I. Lemeshevskaya
O. I. Lemeshevskaya
ATA. D. Tolkach
A. D. Tolkach
EPE. V. Parshina
E. V. Parshina
TNT. P. Nikitina
T. P. Nikitina
AZA. B. Zulkarnaev
A. B. Zulkarnaev
TITatyana Ionova
Tatyana Ionova
Background . Chronic kidney disease-associated pruritus (CKD-aP) can significantly impair quality of life by negatively affecting patient psycho-emotional well-being and sleep quality, while also increasing the risk of hospitalizations and mortality. In Russia, this issue remains understudied. Objective: to assess the prevalence of pruritus and its impact on various aspects of quality of life in a Russian cohort of patients with CKD receiving maintenance hemodialysis. Methods . The cross-sectional study included 225 patients from two dialysis centers with who has been receiving hemodialysis for more than 3 months. The presence and severity of CKD-aP were assessed using the following validated instruments: WI-NRS, Skindex-16, Itch MOS, and the 5-D Itch Scale. Results. CKD-aP was identified in 52% of the patients, with 16% [95% CI: 11; 21] experiencing moderate-to-very severe pruritus (WI-NRS ≥4). The most commonly affected body areas were the back (53%), head (35%), shins (32%), and thighs (25%). Patients with CKD-aP, particularly those with moderate-to-severe pruritus, demonstrated more pronounced sleep disturbances. Sleep Problem Index II (SPI-II) scores were 13.3 [Q1-Q3: 0.0; 33.3] in patients without pruritus, 20 [6.7; 33.3] in those with mild pruritus, and 33.3 [20.0; 60.0] in those with moderate-to-severe pruritus (p=0.001). Patients with moderate-to-severe pruritus also had significantly higher Skindex-16 total and subscales score compared to those with mild pruritus: total score 20.7 [8.9; 35.3] vs. 7.4 [2.8; 15.5] (p<0.001), emotional subscale 14.3 [2.4; 47.6] vs. 5.2 [0.0; 16.7] (p<0.001), and symptomatic subscale 31.3 [12.5; 50.0] vs. 12.5 [4.2; 20.8] (p<0.001). The total score on the 5-D Itch Scale was also higher in patients with CKD-aP, particularly in the moderate-to-severe group: 6.0 [5.0; 8.0] in patients without pruritus, 10.0 [8.0; 11.0] in those with mild pruritus, and 13.0 [11.0; 15.0] in those with moderate-to-severe pruritus (p<0.001). Patients with pruritus had higher creatinine levels: 804.8 (217.4) μmol/L vs. 727.8 (197.8) μmol/L in patients without pruritus, p=0.0091. Conclusions . CKD-aP is highly prevalent in a Russian cohort of patients receiving maintenance hemodialysis. Patients with pruritus, particularly of severe pruritus, experience substantial impairment in overall quality of life and across multiple domains, including sleep, daily activities, and emotional well-being.